Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer

Ohashi N,Arita K,Haruko Daga,Mito A,Ryohei Nishino,Chie Moritani,Kenji Nakamura,Daido K

Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer

2004

Ohashi N
Arita K
Haruko Daga
Mito A
Ryohei Nishino
Chie Moritani
Kenji Nakamura
Daido K

7287 Background:This phase I/II study of carboplatin (C) and weekly paclitaxel (P) for advanced non-small cell lung cancer (NSCLC) aimed to determine maximum tolerated dose (MTD) and dose limiting ...

Keywords:

Carboplatin
Paclitaxel
Pathology
Cancer research
Lung cancer
Medicine
Internal medicine
Oncology
phase i ii
non small cell
weekly paclitaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations